Filing Details
- Accession Number:
- 0001576427-21-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-11 13:00:00
- Reporting Period:
- 2021-05-07
- Accepted Time:
- 2021-05-11 18:30:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1576427 | Criteo S.a. | CRTO | Services-Advertising Agencies (7311) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1769573 | Ryan Damon | C/O Criteo Legal Dept. 387 Park Avenue South, 12Th Floor New York NY 10016 | Evp, Gen Counsel, Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2021-05-07 | 40,938 | $21.32 | 174,962 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2021-05-07 | 12,467 | $38.83 | 162,495 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-05-07 | 40,938 | $38.25 | 121,557 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (right to buy) | Disposition | 2021-05-07 | 40,938 | $0.00 | 40,938 | $21.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,562 | 2028-10-25 | No | 4 | M | Direct |
Footnotes
- The Ordinary Shares may be represented by American Depository Shares, each of which represents One Ordinary Share.
- The exercise price of the stock option is 18.72 euros. The U.S. dollar equivalent of the exercise price is $21.32 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389).
- For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- Stock option granted on October 25, 2018 under the Issuer's 2016 Stock Option Plan. One-fourth of the grant vests on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterlythereafter, subject to continued service through each vesting date.